Research location
Ladysmith
KwaZulu-Natal, South Africa
Advertisement
Research activity in Ladysmith
KwaZulu-Natal, South AfricaCureCurrent currently publishes aggregate city-level research activity for this location: 14 trials and 14 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ladysmith
14 linked trials · page 1 of 1A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)NCT07071623 · 2025-11-10 · 1 site observation
RECRUITING
A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their InfantsNCT06325657 · 2024-03-12 · 1 site observation
COMPLETED
Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)NCT06045507 · 2023-11-08 · 1 site observation
COMPLETED
A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African WomenNCT05746065 · 2022-08-01 · 1 site observation
COMPLETED
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of ConcernNCT05168813 · 2021-12-01 · 1 site observation
COMPLETED
Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)NCT04644029 · 2021-02-24 · 1 site observation
TERMINATED
Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected AdultsNCT02915016 · 2016-12-07 · 1 site observation
COMPLETED
Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South AfricaNCT02968849 · 2016-10-26 · 1 site observation
COMPLETED
To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative WomenNCT02862171 · 2016-07-12 · 1 site observation
COMPLETED
Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring TrialsNCT01618058 · 2012-10-04 · 1 site observation
COMPLETED
Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative WomenNCT01539226 · 2012-03-27 · 1 site observation
COMPLETED
A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaNCT01337570 · 2011-07-01 · 1 site observation
WITHDRAWN
A Safety Study of Dapivirine Vaginal Ring in AfricaNCT01071174 · 2010-04-01 · 1 site observation
COMPLETED
An Expanded Safety Study of Dapivirine Gel 4759 in AfricaNCT00917891 · 2009-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.